正在招募
Phase 2
药物
clinicaltrials.gov
NCT07085169
海外临床试验导航
结直肠癌
帮助用户按结肠癌、直肠癌、MSI/MMR、RAS、BRAF、HER2 等方向检索海外公开临床试验。
Synced trials
当前同步到的治疗类试验
以下记录来自公开临床试验数据库，已按招募状态、治疗目的、干预类型和癌症相关性做初步过滤。本站不判断患者是否符合入组条件，请以官方页面、医生和研究团队意见为准。
招募状态和入组条件可能随时变化。请以官方页面、医院和研究机构信息为准，并带给主治医生或肿瘤科医生讨论。
状态
全部
试验阶段
全部
治疗类型
全部
国家/地区
全部
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
正在招募
Phase 3
生物制剂药物
clinicaltrials.gov
NCT06997497
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07085091
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07066657
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT05768503
Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06609434
The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal Cancer
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06910657
IDOV-Immune for Advanced Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07543744
A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07044921
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
正在招募
Phase 1
药物
clinicaltrials.gov
NCT04991948
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04771520
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07504523
Personalized T-Cell Therapy iNeo-Vac-T01 in Advanced Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05854498
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07510932
Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients (FIRST-K)
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07227168
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07020221
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
正在招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT06149481
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
即将招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06665087
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06873763
Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05129774
Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07233850
A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers
即将招募
Phase 2
药物
clinicaltrials.gov
NCT04845490
Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
即将招募
Phase 3
药物
clinicaltrials.gov
NCT06616259
First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study
正在招募
Phase 2
药物
clinicaltrials.gov
NCT03401294
Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07656766
Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07337551
Gossypol Acetate + FOLFIRI + Bev in mCRC With TP53-Mutant and LRPPRC Positive
正在招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT07079631
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT07410494
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
正在招募
Phase 3
生物制剂药物
clinicaltrials.gov
NCT06662786
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06128551
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
即将招募
阶段未标明
药物
clinicaltrials.gov
NCT06115733
Study of Fuquinitinib Combined With Capecitabine First-line Maintenance in the Treatment of Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06184698
Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer
即将招募
Phase 2, Phase 3
药物手术/操作
clinicaltrials.gov
NCT07321847
Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06566755
Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT07462650
Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06974110
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07309289
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
即将招募
Phase 2
生物制剂手术/操作
clinicaltrials.gov
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06999252
Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06992648
Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer
正在招募
Phase 1
联合产品药物其他
clinicaltrials.gov
NCT06789172
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06867822
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT07341737
SL-28 for Advanced Solid Tumours
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07503756
JS212 Combination Therapies in Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT05379595
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06356584
Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07059338
Dual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06300463
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT07007728
Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07076823
Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06008054
A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
即将招募
Phase 1
生物制剂药物
clinicaltrials.gov
NCT06283134
A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer
即将招募
Phase 4
药物
clinicaltrials.gov
NCT07446465
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07025239
QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06324357
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT04547166
A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
正在招募
Phase 1, Phase 2
生物制剂药物手术/操作
clinicaltrials.gov
NCT07147231
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06783569
A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
即将招募
Phase 1
药物
clinicaltrials.gov
NCT07566897
A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05759923
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours
正在招募
Phase 1, Phase 2
药物其他
clinicaltrials.gov
NCT06922383
A Clinical Study of Arfolitixorin in Patients With mCRC
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06252649
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05746897
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07683403
Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer
即将招募
Phase 1
药物
clinicaltrials.gov
NCT07658196
TLR9 Immunotherapy for Peritoneal Carcinomatosis
正在招募
Phase 2
联合产品药物
clinicaltrials.gov
NCT06949982
Efficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regorafenib In Participants With Refractory Metastatic Colorectal Cancer With Mutations In RAS Genes
正在招募
Phase 3
药物手术/操作
clinicaltrials.gov
NCT05797077
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06412198
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07175636
QL1706 With Short-Course Radiotherapy and Chemotherapy for MSS Rectal Cancer
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06226857
Other Oncogene Mutations for Anti-EGFR Efficacy in Patients With Left-sided RAS-wild Type Metastatic Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05283330
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
正在招募
EARLY / Phase 1
药物
clinicaltrials.gov
NCT06621173
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06010862
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07361003
A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06858969
Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer
即将招募
EARLY / Phase 1
药物其他
clinicaltrials.gov
NCT07318389
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07229846
A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation
即将招募
Phase 3
生物制剂
clinicaltrials.gov
NCT07595276
Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07169734
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07407465
Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
正在招募
阶段未标明
放疗
clinicaltrials.gov
NCT04221893
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
正在招募
Phase 1, Phase 2
联合产品药物
clinicaltrials.gov
NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07020117
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06625775
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT04014530
Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study
正在招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT05733000
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05727163
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06411600
Combination Therapy for BRAF-V600E Metastatic CRCm
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07610798
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05186116
LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis
即将招募
Phase 1, Phase 2
药物手术/操作
clinicaltrials.gov
NCT07594626
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
即将招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT07551778
Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07622550
A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance
即将招募
Phase 1
药物
clinicaltrials.gov
NCT07649655
EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer
正在招募
Phase 1
生物制剂药物手术/操作
clinicaltrials.gov
NCT06696768
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06176885
Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT06934538
First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05581004
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07021950
AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06244771
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
即将招募
Phase 1
生物制剂药物手术/操作
clinicaltrials.gov
NCT07363408
Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07435584
Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE)
即将招募
Phase 1
药物
clinicaltrials.gov
NCT07416552
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT05759728
A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
即将招募
Phase 1
药物
clinicaltrials.gov
NCT07656038
Nelmastobart in Combination With Tas-102 and Bevacizumab in Recurrent/Metastatic Colorectal Cancer
即将招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07535632
SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07446322
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
正在招募
阶段未标明
药物手术/操作
clinicaltrials.gov
NCT03494946
Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer
即将招募
阶段未标明
药物
clinicaltrials.gov
NCT04562727
Microwave Ablation Combined With Chemotherapy for Colorectal Liver Metastases： a Multicenter Cohort Study
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05806931
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
即将招募
Phase 1
药物放疗
clinicaltrials.gov
NCT07453875
LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT06243393
Sacituzumab Govitecan in Metastatic Colorectal Cancer
正在招募
Phase 2
药物其他
clinicaltrials.gov
NCT05360277
Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06333314
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
即将招募
Phase 3
药物
clinicaltrials.gov
NCT06343116
Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory Metastatic Colorectal Cancer
正在招募
阶段未标明
器械手术/操作
clinicaltrials.gov
NCT02886104
Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07515963
FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06824064
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06134388
Sulfasalazine in Patients With Metastatic Colorectal Cancer
正在招募
EARLY / Phase 1
药物
clinicaltrials.gov
NCT07172282
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07691489
A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07150403
Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07286695
Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT05008809
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07397338
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06607458
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
正在招募
Phase 2
放疗
clinicaltrials.gov
NCT06130280
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06679673
SHR-1701 Combined with SHR2554 and BP102 for MCRC
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06547203
Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
即将招募
Phase 4
药物
clinicaltrials.gov
NCT07094893
Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06887218
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06979908
A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06959550
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07529808
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
即将招募
阶段未标明
药物
clinicaltrials.gov
NCT07014254
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07284394
Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their Disease
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06558773
GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT04959604
Lymph Node Mapping Via Flourescent Dye in Colon Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06475352
Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme
即将招募
Phase 1
药物
clinicaltrials.gov
NCT06614751
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07257653
The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06543836
ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06856187
Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer
正在招募
Phase 2
生物制剂
clinicaltrials.gov
NCT06522919
Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer
正在招募
EARLY / Phase 1
生物制剂
clinicaltrials.gov
NCT07328087
COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07261709
Trifluridine/Tipiracil Plus Fruquintinib vs. Trifluridine/Tipiracil Plus Bevacizumab in Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-Label, Non-Inferiority Trial
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05319314
LYL273 for Patients With Relapsed or Refractory mCRC
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT07221357
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
正在招募
Phase 1
药物手术/操作
clinicaltrials.gov
NCT06654037
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07268677
A Single-arm Clinical Study Evaluating Pirfenidone and Sintilimab in Combination With Standard Neoadjuvant Chemotherapy for Colorectal Cancer Patients With Peritoneal Metastasis.
正在招募
Phase 2
器械药物
clinicaltrials.gov
NCT06590259
A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06485713
Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07389265
Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06589440
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07559760
New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07677579
NIMBLE-CRC: NeoImmunoModulation Before Leveraging Excision in Colorectal Rectal Cancer
即将招募
Phase 2, Phase 3
联合产品药物
clinicaltrials.gov
NCT07509398
FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07189871
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06043466
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06728072
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06008119
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
即将招募
Phase 2
联合产品
clinicaltrials.gov
NCT05359393
A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07503808
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT01479608
Liver Transplantation and Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06685276
Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06853496
Study of a Tankyrase Inhibitor RK-582 for Patients With Unresectable Metastatic Colorectal Cancer
正在招募
Phase 2
器械药物
clinicaltrials.gov
NCT07130903
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05229003
Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07631884
Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05856981
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06589830
TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07007767
Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies）
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05296681
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
正在招募
Phase 1
药物放疗
clinicaltrials.gov
NCT06848465
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
正在招募
Phase 2
器械药物
clinicaltrials.gov
NCT05286814
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT03947385
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
正在招募
阶段未标明
药物
clinicaltrials.gov
NCT06613113
Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.
正在招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT06530303
Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07178717
A Study to Characterize Encorafenib Plus Cetuximab as Rechallenge Treatment for BRAF V600E-mutant Metastatic Colorectal Cancer Patients After Previous Therapy With BRAF Inhibitors-based Combinations
正在招募
Phase 1
药物
clinicaltrials.gov
NCT04999761
AB122 Platform Study
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07500298
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT06681038
Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02)
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07070713
Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07454642
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
正在招募
EARLY / Phase 1
药物
clinicaltrials.gov
NCT07050394
A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
正在招募
Phase 4
药物
clinicaltrials.gov
NCT06090994
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06973343
Sintilimab Plus Bevacizumab and Chemotherapy in MSS/pMMR Colorectal With no Liver Metastasis
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05462236
MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer
即将招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06788171
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06341296
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT05720559
Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06218810
Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05985954
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06440005
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06825624
ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06445062
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07284849
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
即将招募
Phase 2
联合产品药物放疗
clinicaltrials.gov
NCT07381309
Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06218914
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07395063
A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond.
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05725200
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06980532
Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07405736
Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06513221
A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab
正在招募
阶段未标明
药物放疗
clinicaltrials.gov
NCT06551207
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
即将招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT06959693
A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)
正在招募
Phase 2
联合产品
clinicaltrials.gov
NCT06555133
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
正在招募
Phase 1
药物
clinicaltrials.gov
NCT03715933
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06593548
Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07446387
A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer
正在招募
Phase 3
生物制剂药物
clinicaltrials.gov
NCT07222800
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07030257
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
正在招募
阶段未标明
药物其他手术/操作
clinicaltrials.gov
NCT06449937
Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07535112
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05954429
A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07133750
PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
正在招募
Phase 2
联合产品
clinicaltrials.gov
NCT06889610
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07463599
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07194616
Rectal Cancer CTC Trial
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06733038
FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
即将招募
Phase 1, Phase 2
联合产品
clinicaltrials.gov
NCT06047015
Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06841159
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
即将招募
Phase 3
药物
clinicaltrials.gov
NCT06446557
De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06978400
A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06642844
Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
正在招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT07589517
Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07244705
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07134205
The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer
正在招募
阶段未标明
诊断检测手术/操作
clinicaltrials.gov
NCT04743102
Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer
正在招募
Phase 3
生物制剂药物
clinicaltrials.gov
NCT03303495
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06746545
A Prospective, Open-label, Single-arm Phase II Clinical Study of Fruquintinib Combined With S-1 for the Treatment of Metastatic Colorectal Cancer.
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06856837
- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06255379
Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06835569
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
正在招募
Phase 3
药物手术/操作
clinicaltrials.gov
NCT05815082
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
正在招募
Phase 2
联合产品药物
clinicaltrials.gov
NCT07079462
Comparing 18F-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus Second-Line Standard Therapy in Colorectal Cancer With Peritoneal Metastasis
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07550088
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
即将招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT07391566
LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05848739
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
正在招募
Phase 1, Phase 2
生物制剂诊断检测
clinicaltrials.gov
NCT06051695
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06195670
Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06640166
Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
正在招募
Phase 4
药物手术/操作
clinicaltrials.gov
NCT05250648
Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07621159
A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06663839
A Study of NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05185245
Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06764680
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT04222413
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07204574
The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06012734
LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07381764
ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05240950
Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07376707
A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06265025
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06792435
XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05786924
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT04689347
5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07621497
FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06553885
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
正在招募
Phase 1
药物
clinicaltrials.gov
NCT03692429
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05611034
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT05427487
Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours
正在招募
阶段未标明
放疗
clinicaltrials.gov
NCT06462963
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07398326
Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07281716
Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05962502
Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07549412
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06937177
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing Chemotherapy
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06423937
Fruquintinib Plus Camrelizumab and HAIC in the Treatment of Non-MSI-H Advanced Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06525428
Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
即将招募
阶段未标明
手术/操作放疗
clinicaltrials.gov
NCT05808790
Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy
正在招募
Phase 2
联合产品药物手术/操作
clinicaltrials.gov
NCT06580574
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
正在招募
Phase 4
药物
clinicaltrials.gov
NCT06118762
Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07255664
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06778863
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
正在招募
EARLY / Phase 1
生物制剂
clinicaltrials.gov
NCT06937567
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
正在招募
Phase 2
联合产品药物
clinicaltrials.gov
NCT05057052
Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06634875
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06663319
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05086692
A Beta-only IL-2 ImmunoTherapY Study
正在招募
阶段未标明
药物
clinicaltrials.gov
NCT06126419
Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06882746
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
正在招募
Phase 3
药物其他
clinicaltrials.gov
NCT05861505
COLLISION RELAPSE Trial
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07318805
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07277322
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
即将招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07502014
A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT05078047
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07011576
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
正在招募
EARLY / Phase 1
药物放疗
clinicaltrials.gov
NCT07128355
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
正在招募
Phase 3
药物手术/操作
clinicaltrials.gov
NCT05673148
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05310643
Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC
正在招募
Phase 1
诊断检测药物
clinicaltrials.gov
NCT04929223
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
即将招募
阶段未标明
放疗
clinicaltrials.gov
NCT06053996
Hepatopulmonary Radio-sterilization With Immunotherapy
正在招募
Phase 2, Phase 3
手术/操作放疗
clinicaltrials.gov
NCT06185556
COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06776757
Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06321081
ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06763029
Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT03488953
Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver Metastases
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06917079
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06833866
Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT04585750
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
即将招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07587827
Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT05963490
Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05195710
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
即将招募
EARLY / Phase 1
药物
clinicaltrials.gov
NCT07627191
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
正在招募
Phase 2
器械药物手术/操作
clinicaltrials.gov
NCT07201519
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06242067
Second-line Treatment of Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07148128
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
即将招募
Phase 2
药物手术/操作放疗
clinicaltrials.gov
NCT07243938
Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT05877599
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
即将招募
Phase 2
药物
clinicaltrials.gov
NCT05747716
SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRC
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05970302
XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC
即将招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT07693751
A Study Testing SOT109 for the First Time in Patients, to Assess How Safe SOT109 is, How Well it Works, and How the Body Handles it in Patients With Advanced Colorectal Cancer That Can Not be Removed by Surgery or is Metastatic
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07051785
Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer
正在招募
Phase 3
药物其他
clinicaltrials.gov
NCT03803553
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05870800
Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06282445
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
生物制剂诊断检测
clinicaltrials.gov
NCT06682793
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07525206
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
正在招募
Phase 2
器械药物
clinicaltrials.gov
NCT06563986
FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06040541
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06540326
Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
即将招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT07591597
A Multicenter, Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Concurrent Combination Therapy of S-531011 Plus Fruquintinib or S-531011 Plus Fruquintinib Plus Pembrolizumab in Patients With MSS/pMMR Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06493760
A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06245356
Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07224022
Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05985109
KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
正在招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT05007132
Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
正在招募
Phase 1, Phase 2
药物手术/操作
clinicaltrials.gov
NCT03965234
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07348211
First in Human Study of SIM0610 in Solid Tumors
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07362836
Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS)
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06200831
Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases
正在招募
阶段未标明
药物
clinicaltrials.gov
NCT06456515
Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC
正在招募
Phase 1
药物手术/操作
clinicaltrials.gov
NCT06269978
Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer
即将招募
Phase 1
药物
clinicaltrials.gov
NCT06882915
Efficacy and Safety of Trifluridine/Tipiracil (TAS-102) Combined With Bevacizumab and Serplulimab in Patients With Metastatic Colorectal Cancer Undergoing Cytoreductive Surgery: A Single-Arm, Single-Center Clinical Study
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07358585
A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07653685
A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07213570
STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06192680
Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06555003
DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05700656
Galunisertib Combined With Capecitabine in Advanced CRC With PM
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07359456
Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases
正在招募
Phase 3
药物
clinicaltrials.gov
NCT02885753
Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06484153
Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07003022
Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07009145
QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07229872
A Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Fruquintinib in the Treatment of Immunodominant pMMR/MSS Metastatic Colorectal Cancer That Has Failed Second-line or Above Treatment
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07321106
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06126406
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors
即将招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT07662031
Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07490119
Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06643793
Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC
正在招募
Phase 3
药物
clinicaltrials.gov
NCT05253651
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
正在招募
Phase 3
生物制剂药物手术/操作
clinicaltrials.gov
NCT05863195
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
正在招募
Phase 1
生物制剂Dietary_Supplement其他
clinicaltrials.gov
NCT06336902
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07506109
A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06509126
Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07623642
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
正在招募
Phase 3
其他手术/操作
clinicaltrials.gov
NCT06563388
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT07570914
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases
即将招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT07260058
Immune Cell Therapy for Advanced Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06820463
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06792695
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
正在招募
Phase 2
放疗
clinicaltrials.gov
NCT07292298
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07589205
Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06951503
AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT04678583
Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05771181
Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06821048
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT04776655
Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB
正在招募
Phase 4
药物
clinicaltrials.gov
NCT06562543
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06500052
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07150247
Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer
正在招募
Phase 2
放疗
clinicaltrials.gov
NCT02185443
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06411691
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06756035
CT-95 in Advanced Cancers Associated With Mesothelin Expression
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07629960
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07012954
ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04701476
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
正在招募
Phase 1, Phase 2
药物手术/操作
clinicaltrials.gov
NCT05691491
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
即将招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT07585279
A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07659795
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
即将招募
Phase 1
药物
clinicaltrials.gov
NCT07543471
A Phase I Multicentre Randomized Double-Blind Parallel-Controlled Study of HLX05-N vs. ERBITUX® in Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07202364
A Study of YL202 in Patients With Advanced Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06202001
Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07000305
A Study of Cetuximabβ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07353268
Phase Ib/II Study of QL1706 + Fruquintinib + SCRT vs. Standard Third-Line Therapy in Unresectable Liver-Metastatic pMMR/MSS Colorectal Cancer: Safety, Tolerability, and Efficacy.
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05706129
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
即将招募
Phase 3
诊断检测药物
clinicaltrials.gov
NCT07004413
Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients
正在招募
Phase 1
药物手术/操作
clinicaltrials.gov
NCT05803382
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06341309
Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07071844
BETWEEN: Biweekly Bevacizumab + Trifluridine/Tipiracil to Reduce Grade 3-4 Neutropenia in mCRC Patients
即将招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06835179
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.
即将招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07409805
YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment
正在招募
Phase 2
放疗
clinicaltrials.gov
NCT05775146
SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
即将招募
Phase 2
其他手术/操作
clinicaltrials.gov
NCT07333651
125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer
即将招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07610707
YMN-A02 for Advanced pMMR Colorectal Cancer With Liver Metastases
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06972498
A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets
正在招募
Phase 2
生物制剂联合产品
clinicaltrials.gov
NCT06225843
Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07042685
Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT07612007
HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07636785
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
正在招募
Phase 1, Phase 2
联合产品药物
clinicaltrials.gov
NCT05093907
A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05959356
Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06275958
DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT07462143
A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06018714
Efficacy of Modified Fruquintinib in Colorectal Cancer Liver Metastases: A Phase II Study
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07458347
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
正在招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT01174121
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06992258
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07349043
A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritoneal Metastasis of Colorectal Cancer
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT07410676
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT04516681
Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer
正在招募
Phase 3
生物制剂药物
clinicaltrials.gov
NCT06750094
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06714357
ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
正在招募
Phase 2, Phase 3
联合产品
clinicaltrials.gov
NCT06958419
Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)
正在招募
Phase 1
药物
clinicaltrials.gov
NCT04511039
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06630624
Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07314294
Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients
正在招募
EARLY / Phase 1
联合产品
clinicaltrials.gov
NCT07193862
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07061210
An Explorative Study of HRS-2189 Combined With Adebrelimab and BP102 for Metastatic Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06205836
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05239546
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07223424
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06002789
Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07213609
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06520683
Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07409844
Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT05236972
PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
正在招募
Phase 3
生物制剂药物
clinicaltrials.gov
NCT05855200
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT05841134
Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06686576
A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06529523
Tislelizumab in People With Colorectal Cancer
正在招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT06903858
Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06948448
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT05770102
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
正在招募
Phase 2
生物制剂
clinicaltrials.gov
NCT06698757
Different Cycles of Preoperative Neoadjuvant Sintilimab in Mismatch-repair Deficient/microsatellite Instability-high, Locally Advanced Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07412613
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
正在招募
Phase 1, Phase 2
药物放疗
clinicaltrials.gov
NCT04636008
Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT06646445
Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study.
即将招募
Phase 2
药物其他手术/操作
clinicaltrials.gov
NCT07403877
Neoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT03926338
Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06218888
A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT05136326
Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07025850
Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06829355
"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04109755
Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
正在招募
Phase 2, Phase 3
联合产品
clinicaltrials.gov
NCT06958432
Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07448142
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
正在招募
Phase 2
联合产品
clinicaltrials.gov
NCT07458529
Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT06280495
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
正在招募
Phase 2
联合产品
clinicaltrials.gov
NCT07279077
Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06168786
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
即将招募
Phase 2
药物其他放疗
clinicaltrials.gov
NCT07527520
Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial
正在招募
Phase 2
药物
clinicaltrials.gov
NCT03026140
Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07106034
Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial
正在招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT06885385
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
即将招募
Phase 2
联合产品
clinicaltrials.gov
NCT07622771
Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical Trial
即将招募
Phase 2
药物其他手术/操作
clinicaltrials.gov
NCT07162714
SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer
即将招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06872606
Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer
即将招募
Phase 2
药物手术/操作放疗
clinicaltrials.gov
NCT06919510
A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06949111
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07510308
Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06930118
The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07544784
AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06391905
PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06014944
Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody
即将招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT06443671
Neoadjuvant Fruquintinib Plus Tislelizumab Combined With mCapeOX Versus CapeOX for Mid-high pMMR/MSS Locally Advanced Rectal Cancer
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07154316
Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05005403
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
正在招募
Phase 2
药物手术/操作放疗
clinicaltrials.gov
NCT06850103
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
正在招募
Phase 2
药物手术/操作放疗
clinicaltrials.gov
NCT06908031
SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer(CRIT)
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07068763
Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07644286
A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiotherapy for Refractory pMMR/MSS Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06497985
A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
正在招募
Phase 2
药物手术/操作放疗
clinicaltrials.gov
NCT05576480
SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07528209
Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06680739
Single cEll pRofiling PErsistaNce To ImmuNothErapy
正在招募
Phase 3
生物制剂
clinicaltrials.gov
NCT05752136
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07156682
QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07527858
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05731726
Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06709885
HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07132008
Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer
即将招募
Phase 3
药物
clinicaltrials.gov
NCT06832917
Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III)
即将招募
EARLY / Phase 1
联合产品
clinicaltrials.gov
NCT06931873
Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06594692
Node-Sparing Short-Course Radiation With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer: A Randomized, Prospective, Multicenter Study
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07381400
Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally Advanced Rectal Cancer (FIRM02 Study)
正在招募
Phase 2
药物手术/操作放疗
clinicaltrials.gov
NCT06204094
Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer
正在招募
Phase 2
联合产品
clinicaltrials.gov
NCT06911684
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.
正在招募
Phase 2
联合产品
clinicaltrials.gov
NCT06923345
Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)
正在招募
阶段未标明
药物放疗
clinicaltrials.gov
NCT05877573
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06254521
The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06207656
Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07347951
A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
即将招募
Phase 2
药物手术/操作放疗
clinicaltrials.gov
NCT06599827
Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC
正在招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT05914389
Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
即将招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07411781
PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06791512
mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
即将招募
Phase 2
放疗
clinicaltrials.gov
NCT07394192
Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-III Rectal Cancer
正在招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT06567782
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
正在招募
Phase 1
联合产品药物
clinicaltrials.gov
NCT06447662
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06603376
Irinotecan Hydrochloride Liposome Injection (Ⅱ) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05706779
Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06253871
A Phase 1/1b Study of IAM1363 in HER2 Cancers
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05672524
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07631871
An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06562192
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07384377
JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan
正在招募
Phase 2
药物其他放疗
clinicaltrials.gov
NCT04899908
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
即将招募
Phase 1
药物
clinicaltrials.gov
NCT07036185
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07192068
Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07483684
A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07509424
Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07108127
Efficacy and Safety of Trastuzumab Biosimilars and Pertuzumab Biosimilars Combined With Chemotherapy for Neoadjuvant Treatment of Patients With Locally Advanced HER2-positive Rectal Cancer
正在招募
Phase 2
生物制剂其他手术/操作
clinicaltrials.gov
NCT07405476
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07261631
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06434597
A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT03740256
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT05786716
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
即将招募
Phase 2
药物
clinicaltrials.gov
NCT05985707
KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma
正在招募
阶段未标明
药物放疗
clinicaltrials.gov
NCT06349044
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.
第 1 页
没有符合当前筛选条件的试验。
Subtypes
建议拆分方向
结肠癌 colon cancer直肠癌 rectal cancer转移性结直肠癌 metastatic colorectal cancerMSI-H / dMMRMSS / pMMRKRAS / NRASBRAF V600EHER2-positiveFirst lineSecond line
Keyword guide
这些关键词怎么理解
| 术语 | 中文意思 | 对找临床试验有什么用 |
|---|---|---|
| 结直肠癌 / Colorectal cancer | 包括结肠癌和直肠癌。不同部位、分期和分子特征会影响试验条件。 | 可以先用 colorectal cancer broad search，再用 colon 或 rectal 细化。 |
| MSI-H / dMMR | 提示错配修复功能异常或微卫星高度不稳定。 | 可以找免疫治疗、checkpoint inhibitor 等相关试验。 |
| MSS / pMMR | 微卫星稳定或错配修复功能完整，是转移性结直肠癌中常见情况。 | 很多试验会区分 MSI-H 和 MSS，MSS 患者常需要单独搜索。 |
| KRAS / NRAS | RAS 基因状态会影响部分靶向治疗选择和试验入组。 | 试验可能要求 RAS wild-type，或针对特定 RAS 突变。 |
| BRAF V600E | BRAF 的一种具体突变类型。 | 可以找 BRAF/MEK/EGFR 联合靶向相关试验。 |
| HER2-positive | 部分结直肠癌可能存在 HER2 扩增或高表达。 | 可以找 HER2 靶向药或 ADC 相关试验。 |
| 转移性结直肠癌 / metastatic colorectal cancer | 癌症已经扩散到远处器官，比如肝、肺、腹膜等。 | 很多试验会限定 metastatic 或 unresectable 患者。 |
Recruitment status
常见招募状态
| Recruiting | 正在招募，可能仍可申请参加。 |
| Not yet recruiting | 尚未开始招募，可关注后续开放时间。 |
| Active, not recruiting | 试验仍在进行，但通常不再招新患者。 |
| Completed | 试验已经完成。 |
| Terminated | 试验提前终止。 |
| Unknown | 公开页面上的状态不明确或未及时更新。 |
Before contact
联系前准备资料
- 病理诊断报告
- 影像报告：CT / MRI / PET-CT
- 既往治疗记录
- 用药历史
- 基因检测报告
- 最近血液检查结果
- 出院小结
- 主治医生英文病情摘要，如果有
- 护照和签证情况，如果考虑出国
Filters
搜索时重点关注
- Recruiting / Not yet recruiting
- Location
- Age
- Phase
- Inclusion Criteria
- Exclusion Criteria
- Prior treatments
- Biomarker / mutation requirements
- ECOG performance status
- 是否接受 international patients
- 是否需要长期停留在试验所在地
- 费用、保险、翻译、住宿和陪护安排
Ask your doctor
可以带去问医生的问题
- 我的病理类型是否符合这个试验？
- 我之前用过的药会不会影响入组？
- 我是否需要做基因检测？
- 这个试验是几期？主要目的是什么？
- 参加试验会不会影响当前治疗？
- 如果去国外参加，风险和成本大概有哪些？
- 研究团队是否接受海外患者？
请将检索到的临床试验信息带给主治医生或肿瘤科医生讨论。本站不判断患者是否适合任何临床试验。